Literature DB >> 1942404

Assessing risk for pelvic inflammatory disease and its sequelae.

A E Washington1, S O Aral, P Wølner-Hanssen, D A Grimes, K K Holmes.   

Abstract

To assess the risk for pelvic inflammatory disease (PID), a practitioner must evaluate the likelihood that a woman has PID or will be exposed to a sexually transmitted disease causing PID. Successful risk assessment depends on accurate information about variables influencing risk of PID. To determine the current state of knowledge about PID risk variables, we examined data in published reports. Data on each risk variable were scrutinized to discern which link(s) in the PID risk chain it affects (acquisition of a sexually transmitted disease, development of PID, or development of PID sequelae) and whether it is a risk marker or a risk factor. Most PID risk variables, particularly sexual behaviors, are associated with acquisition of a sexually transmitted disease, rather than development of PID itself. With the exception of age, demographic and social indicators of risk appear to be risk markers, while contraceptive practices appear more often to be risk factors than risk markers. Additional data are needed for most PID risk variables confidently to categorize them as risk factors. Enough information is available, however, to begin assessing risk for PID, so that appropriate counseling can ensue and timely diagnosis can be made.

Entities:  

Mesh:

Year:  1991        PMID: 1942404

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  15 in total

Review 1.  Pelvic inflammatory disease epidemiology: what do we know and what do we need to know?

Authors:  I Simms; J M Stephenson
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

Review 2.  Pathogenesis of pelvic inflammatory disease.

Authors:  L Weström; P Wölner-Hanssen
Journal:  Genitourin Med       Date:  1993-02

3.  Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.

Authors:  S Pal; I Theodor; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Assessment of risk for pelvic inflammatory disease in an urban sexual health population.

Authors:  C Marks; R L Tideman; C S Estcourt; G Berry; A Mindel
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

5.  Risk factors associated with pelvic inflammatory disease.

Authors:  I Simms; J M Stephenson; H Mallinson; R W Peeling; K Thomas; R Gokhale; P A Rogers; P Hay; P Oakeshott; J Hopwood; H Birley; M Hernon
Journal:  Sex Transm Infect       Date:  2006-08-10       Impact factor: 3.519

6.  Vagina dentata revisited: gender and asymptomatic shedding of genital herpes.

Authors:  K L Pliskin
Journal:  Cult Med Psychiatry       Date:  1995-12

7.  Women with multiple sexual partners: united states, 1988.

Authors:  S N Seidman; W D Mosher; S O Aral
Journal:  Am J Public Health       Date:  1992-10       Impact factor: 9.308

8.  Is Vaginal Sexual Intercourse Permitted during Menstruation? A Biblical (Christian) and Medical Approach.

Authors:  Elias E Mazokopakis; George Samonis
Journal:  Maedica (Bucur)       Date:  2018-09

Review 9.  Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin.

Authors:  Francesco Cappello; Everly Conway de Macario; Valentina Di Felice; Giovanni Zummo; Alberto J L Macario
Journal:  PLoS Pathog       Date:  2009-08-28       Impact factor: 6.823

10.  Pelvic Abscess after Cesarean Section Treated with Laparoscopic Drainage.

Authors:  Yumi Murayama; Tomohito Tanaka; Hiroshi Maruoka; Atsushi Daimon; Shoko Ueda; Masahide Ohmichi
Journal:  Case Rep Obstet Gynecol       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.